Browsing by Author Stebbing, J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 5 to 9 of 9 < previous 
TitleAuthor(s)Issue date???itemlist.???
The genomics of new drugs in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Stebbing, J.24-Nov-2015-
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaHatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T.24-Nov-2015-
Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseasesPanteli, K. E.; Hatzimichael, E. C.; Bouranta, P.; Katsaraki, A.; Seferiadis, K.; Stebbing, J.; Bourantas, K. L.24-Nov-2015-
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim supportHatzimichael, E.; Benetatos, L.; Stebbing, J.; Kapsali, E.; Panayiotopoulou, S.; Bourantas, K. L.24-Nov-2015-
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseHatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L.24-Nov-2015-